Source: BioPharma-Reporter

BSI received $7.6M in Series A Funding

Followers on Owler

Est. Annual Revenue

$100K-5.0M

Est. Employees

25-100

CEO

Gaston Salinas

CEO Approval Rating

89/100

BSI is a Chile-based biotechnology company that develops botanical materials for sectors including agriculture and healthcare.